Related references
Note: Only part of the references are listed.Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors
Yang Yang et al.
CELL DEATH & DISEASE (2019)
MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition
Rebecca C. Coll et al.
NATURE CHEMICAL BIOLOGY (2019)
MCC950 closes the active conformation of NLRP3 to an inactive state
Ana Tapia-Abelian et al.
NATURE CHEMICAL BIOLOGY (2019)
The neuroprotection of progesterone against Aβ-induced NLRP3-Caspase-1 inflammasome activation via enhancing autophagy in astrocytes
Yang Hong et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
NLRP3 inflammasome activation drives tau pathology
Christina Ising et al.
NATURE (2019)
Aggregated Tau activates NLRP3-ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
Ilie-Cosmin Stancu et al.
ACTA NEUROPATHOLOGICA (2019)
The NLRP3 inflammasome: a new player in neurological diseases
Elif Eren et al.
TURKISH JOURNAL OF BIOLOGY (2019)
Neuroinflammatory responses in Alzheimer's disease
Cira Dansokho et al.
JOURNAL OF NEURAL TRANSMISSION (2018)
Innate Immunity and Neurodegeneration
Larisa I. Labzin et al.
ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Jianlin Qiao et al.
HAEMATOLOGICA (2018)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
NADPH oxidases and ROS signaling in the gastrointestinal tract
Gabriella Aviello et al.
MUCOSAL IMMUNOLOGY (2018)
NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis
Jianlin Qiao et al.
HAEMATOLOGICA (2018)
Amyloid β directly interacts with NLRP3 to initiate inflammasome activation: identification of an intrinsic NLRP3 ligand in a cell-free system
Ayaka Nakanishi et al.
INFLAMMATION AND REGENERATION (2018)
Danger-associated molecular patterns in Alzheimer's disease
Carmen Venegas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Hua Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Autophagy and inflammasomes
James Harris et al.
MOLECULAR IMMUNOLOGY (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
Inflammasome activation and innate immunity in Alzheimer's disease
Michael T. Heneka
BRAIN PATHOLOGY (2017)
Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice
C. Dempsey et al.
BRAIN BEHAVIOR AND IMMUNITY (2017)
Impaired autophagy in macrophages promotes inflammatory eye disease
Andrea Santeford et al.
AUTOPHAGY (2016)
Microglial toll-like receptors and Alzheimer's disease
Fan Su et al.
BRAIN BEHAVIOR AND IMMUNITY (2016)
NF-κB Restricts Inflammasome Activation via Elimination of Damaged Mitochondria
Zhenyu Zhong et al.
CELL (2016)
K+ Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
Christina J. Gross et al.
IMMUNITY (2016)
Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models
Michael J. D. Daniels et al.
NATURE COMMUNICATIONS (2016)
Multiple Cathepsins Promote Pro-IL-1β Synthesis and NLRP3-Mediated IL-1β Activation
Gregory M. Orlowski et al.
JOURNAL OF IMMUNOLOGY (2015)
NALP3 inflammasome activation in protein misfolding diseases
Fushan Shi et al.
LIFE SCIENCES (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Autophagy in Alzheimer's disease
Ameneh Zare-shahabadi et al.
REVIEWS IN THE NEUROSCIENCES (2015)
Anti-inflammatory agents to treat or prevent type 2 diabetes, metabolic syndrome and cardiovascular disease
Nathalie Esser et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome
Mi-Hyang Cho et al.
AUTOPHAGY (2014)
Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
Alvin Lu et al.
CELL (2014)
Mechanisms and Functions of Inflammasomes
Mohamed Lamkanfi et al.
CELL (2014)
IRAK-1 bypasses priming and directly links TLRs to rapid NLRP3 inflammasome activation
Keng-Mean Lin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Love and death: microglia, NLRP3 and the Alzheimer's brain
Tobias Goldmann et al.
CELL RESEARCH (2013)
Mitochondria-targeted drugs enhance Nlrp3 inflammasome-dependent IL-1β secretion in association with alterations in cellular redox and energy status
Joshua Jabaut et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
Deubiquitinases Regulate the Activity of Caspase-1 and Interleukin-1β Secretion via Assembly of the Inflammasome
Gloria Lopez-Castejon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Mitochondrial Reactive Oxygen Species Induces NLRP3-Dependent Lysosomal Damage and Inflammasome Activation
Michelle E. Heid et al.
JOURNAL OF IMMUNOLOGY (2013)
Cutting Edge: TLR Signaling Licenses IRAK1 for Rapid Activation of the NLRP3 Inflammasome
Teresa Fernandes-Alnemri et al.
JOURNAL OF IMMUNOLOGY (2013)
P2X7 receptor-mediated Nlrp3-inflammasome activation is a genetic determinant of macrophage-dependent crescentic glomerulonephritis
Simona Deplano et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2013)
Deubiquitination of NLRP3 by BRCC3 Critically Regulates Inflammasome Activity
Benedicte F. Py et al.
MOLECULAR CELL (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation
Frederick J. Sheedy et al.
NATURE IMMUNOLOGY (2013)
Oligomeric amyloid β induces IL-1β processing via production of ROS: implication in Alzheimer's disease
B. Parajuli et al.
CELL DEATH & DISEASE (2013)
Effects of Interleukin-1β Inhibition With Canakinumab on Hemoglobin A1c, Lipids, C-Reactive Protein, Interleukin-6, and Fibrinogen A Phase IIb Randomized, Placebo-Controlled Trial
Paul M. Ridker et al.
CIRCULATION (2012)
Non-transcriptional Priming and Deubiquitination Regulate NLRP3 Inflammasome Activation
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Redox control of NLRP3 inflammasome activation in health and disease
Anna Rubartelli
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Interleukin-1 Receptor Antagonist: A New Therapy for Type 2 Diabetes Mellitus
Muhammad Sajid Hamid Akash et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Charles A. Dinarello et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Cutting Edge: Reactive Oxygen Species Inhibitors Block Priming, but Not Activation, of the NLRP3 Inflammasome
Franz Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2011)
Blocking IL-1 Signaling Rescues Cognition, Attenuates Tau Pathology, and Restores Neuronal β-Catenin Pathway Function in an Alzheimer's Disease Model
Masashi Kitazawa et al.
JOURNAL OF IMMUNOLOGY (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome
Kiichi Nakahira et al.
NATURE IMMUNOLOGY (2011)
Heterogeneity of CNS myeloid cells and their roles in neurodegeneration
Marco Prinz et al.
NATURE NEUROSCIENCE (2011)
APP Transgenic Mice: Their Use and Limitations
Claudia Balducci et al.
NEUROMOLECULAR MEDICINE (2011)
Disease-associated amyloid and misfolded protein aggregates activate the inflammasome
Seth L. Masters et al.
TRENDS IN MOLECULAR MEDICINE (2011)
Interleukin-1 Blockade With Anakinra to Prevent Adverse Cardiac Remodeling After Acute Myocardial Infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot Study)
Antonio Abbate et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Molecular Mechanism of NLRP3 Inflammasome Activation
Chengcheng Jin et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2010)
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Rongbin Zhou et al.
NATURE IMMUNOLOGY (2010)
CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer
Cameron R. Stewart et al.
NATURE IMMUNOLOGY (2010)
Inflammation, microglia, and alzheimer's disease
Brent Cameron et al.
NEUROBIOLOGY OF DISEASE (2010)
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Jurg Tschopp et al.
NATURE REVIEWS IMMUNOLOGY (2010)
The Inflammasomes: Guardians of the Body
Fablo Martinon et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Mitochondria and reactive oxygen species
Alicia J. Kowaltowski et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Nox proteins in signal transduction
David I. Brown et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis
Luigi Franchi et al.
NATURE IMMUNOLOGY (2009)
Immune Activation in Brain Aging and Neurodegeneration: Too Much or Too Little?
Kurt M. Lucin et al.
NEURON (2009)
Autophagy and the Immune Response to TB
J. Harris et al.
TRANSBOUNDARY AND EMERGING DISEASES (2009)
The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
Luigi Franchi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Inhibitors of cathepsin B improve memory and reduce β-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, β-secretase site of the amyloid precursor protein
Vivian Y. H. Hook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice
Suzanne E. Hickman et al.
JOURNAL OF NEUROSCIENCE (2008)
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer's disease
Melanie Meyer-Luehmann et al.
NATURE (2008)
Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production
Tatsuya Saitoh et al.
NATURE (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle et al.
NATURE IMMUNOLOGY (2008)
Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica
Catherine Dostert et al.
SCIENCE (2008)
COPs and POPs: Modulators of inflammasome activity
Christian Stehlik et al.
JOURNAL OF IMMUNOLOGY (2007)
Intracellular NOD-like receptors in host Defense and disease
Thirumala-Devi Kanneganti et al.
IMMUNITY (2007)
Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration
V. Petrilli et al.
CELL DEATH AND DIFFERENTIATION (2007)
The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1β processing
S. Papin et al.
CELL DEATH AND DIFFERENTIATION (2007)
Caspase-1 inflammasomes in infection and inflammation
Mohamed Lamkanfi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling
Joseph A. Duncan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Pyrin-only protein 2 modulates NFκB and disrupts ASC:CLR interactions
Felipe Bedoya et al.
JOURNAL OF IMMUNOLOGY (2007)
Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation
Andrea Dorfleutner et al.
INFECTION AND IMMUNITY (2007)
The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production
Jae Jin Chae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Cryopyrin activates the inflammasome in response to toxins and ATP
S Mariathasan et al.
NATURE (2006)
Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease
M Kitazawa et al.
JOURNAL OF NEUROSCIENCE (2005)
Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid
Jeffrey M. Craft et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
S Mariathasan et al.
NATURE (2004)
ASC is essential for LPS-induced activation of procaspase-1 independently of TLR-associated signal adaptor molecules
M Yamamoto et al.
GENES TO CELLS (2004)
The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-κB and pro-caspase-1 regulation
C Stehlik et al.
BIOCHEMICAL JOURNAL (2003)
CD36 mediates the innate host response to β-amyloid
JB El Khoury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Inflammation and cerebral amyloidosis are disconnected in an animal model of Alzheimer's disease
J Quinn et al.
JOURNAL OF NEUROIMMUNOLOGY (2003)
Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis
JJ Chae et al.
MOLECULAR CELL (2003)
Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease
GP Lim et al.
JOURNAL OF NEUROSCIENCE (2000)
Interleukin-1 promotes expression and phosphorylation of neurofilament and tau proteins in vivo
JG Sheng et al.
EXPERIMENTAL NEUROLOGY (2000)
Share Paper
